Stay updated on Guselkumab in Psoriasis: Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.

Latest updates to the Guselkumab in Psoriasis: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.4%
- Check21 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check28 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check36 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.6%
- Check64 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check79 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the detailed description of a clinical study evaluating guselkumab for psoriasis, including its methodology, participant criteria, and study duration. The only addition is a reference to a new revision number.SummaryDifference9%
Stay in the know with updates to Guselkumab in Psoriasis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.